$136.38
0.000.00%
Pre-Market: Dec 20, 4:00 PM EDT
Comments
Loading...
Ascendis Pharma (NASDAQ:ASND) Stock, Earnings Estimates, EPS, And Revenue
Ascendis Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 5
EPS Estimate
$-1.290
Quarterly Revenue Estimate
$97.5M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$327.4M
Analyze the earnings history of Ascendis Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Ascendis Pharma (ASND) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $-1.89 | $-1.52 | -24.3 % |
| Jun 2024 | 2024-09-03 | $-2.06 | $-1.56 | -32.0 % |
| Dec 2023 | 2024-02-07 | $-1.66 | $-2.15 | 22.8 % |
| Sep 2023 | 2023-11-07 | $-3.13 | $-2.75 | -13.8 % |
Ascendis Pharma (ASND) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $63.57M | $70.31M | -9.59 % |
| Jun 2024 | 2024-09-03 | $38.76M | $92.74M | -58.2 % |
| Dec 2023 | 2024-02-07 | $148.22M | $97.02M | 52.8 % |
| Sep 2023 | 2023-11-07 | $52.28M | $52.70M | -0.79 % |
FAQ
When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?
Ascendis Pharma (ASND) is scheduled to report earnings on February 5, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Ascendis Pharma (NASDAQ:ASND)?
The Actual EPS was $-1.89, which missed the estimate of $-1.52.
What were Ascendis Pharma’s (NASDAQ:ASND) revenues?
The Actual Revenue was $63.6M, which missed the estimate of $70.3M.
Browse earnings estimates, EPS, and revenue on all stocks.